SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-338110
Filing Date
2017-11-09
Accepted
2017-11-09 08:31:03
Documents
3
Period of Report
2017-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d481387d8k.htm 8-K 14831
2 EX-99.1 d481387dex991.htm EX-99.1 42634
3 GRAPHIC g481387g1109071745827.jpg GRAPHIC 3793
  Complete submission text file 0001193125-17-338110.txt   64097
Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Filer) CIK: 0001656328 (see all company filings)

IRS No.: 273364627 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38155 | Film No.: 171188382
SIC: 2834 Pharmaceutical Preparations